Utilization of genetic information for medicines development and equitable benefit sharing.

Matsuyama, Kotone; Kurihara, Chieko; Crawley, Francis P; Kerpel-Fronius, Sandor

Matsuyama, Kotone; Kurihara, Chieko; Crawley, Francis P; Kerpel-Fronius, Sandor.

Afiliación

Matsuyama K; Department of Health Policy and Management, Nippon Medical School, Tokyo, Japan.
Kurihara C; Kanagawa Dental University, Yokosuka, Kanagawa, Japan.
Crawley FP; Good Clinical Practice Alliance-Europe (GCPA) and Strategic Initiative for Developing Capacity in Ethical Review, Leuven, Belgium.
Kerpel-Fronius S; Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, Semmelweis University, Budapest, Hungary.

Front Genet ; 14: 1085864, 2023.

Article en En | MEDLINE | ID: mdl-37388927

Palabras clave

benefit sharing; global health; global public good; inclusive governance; medicines development; pharmacogenomics

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Aspecto: Ethics Idioma: En Revista: Front Genet Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google